đź’¨ Abstract
Indian pharmaceutical company Alembic Pharmaceuticals reported a 23% drop in third-quarter profit due to weak local sales of drugs used to treat acute illnesses. Its revenue from India, its biggest market, grew 3%, but the segment treating acute conditions saw an 11% decline.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
GRAP 3 curbs revoked in Delhi-NCR amid dip in pollution
Odisha CM sanctions Rs 5 lakh for treatment of girl, house for family
One dead, two missing after car falls into canal in Karnataka
Two crore take 'Amrit Snan' on Basant Panchami without hitch at Maha Kumbh
Summons to Tharoor in defamation case: Delhi court to pass order on Feb 4
NIA nabs 2 suspected to be part of terror outfit working to establish caliphate: Officials
WPL changed conversations around women's cricket, want to see such stories in other events: Smriti
'Rahul Gandhi deliberately spoke falsehood’: Jaishankar on his remarks on Trump inauguration invite
All disabled candidates can use scribes to write exam: SC
Anurag Basu to start shoot for Kartik Aaryan starrer 'Aashiqui 3' next month
Powered by MessengerX.io